These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Extramammary Paget's disease: treatment, prognostic factors and outcome in 76 patients. Hatta N; Yamada M; Hirano T; Fujimoto A; Morita R Br J Dermatol; 2008 Feb; 158(2):313-8. PubMed ID: 18028492 [TBL] [Abstract][Full Text] [Related]
24. Primary extramammary Paget's disease: a clinicopathological study of 28 cases. Zhao Y; Gong X; Li N; Zhu Q; Yu D; Jin X Int J Clin Exp Pathol; 2019; 12(9):3426-3432. PubMed ID: 31934186 [TBL] [Abstract][Full Text] [Related]
25. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease. Aoyagi S; Akiyama M; Shimizu H J Dermatol Sci; 2008 Jun; 50(3):177-84. PubMed ID: 18248961 [TBL] [Abstract][Full Text] [Related]
26. Concordant over-expression of transcription factor Sp1 and vascular endothelial growth factor in extramammary Paget's disease. Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Uchi H; Takahara M; Uenotsuchi T; Tu YT; Urabe K; Furue M Int J Dermatol; 2008 Jun; 47(6):562-6. PubMed ID: 18477144 [TBL] [Abstract][Full Text] [Related]
27. Frozen section-guided wide local excision in the treatment of penoscrotal extramammary Paget's disease. Zhu Y; Ye DW; Chen ZW; Zhang SL; Qin XJ BJU Int; 2007 Dec; 100(6):1282-7. PubMed ID: 17850363 [TBL] [Abstract][Full Text] [Related]
28. Podoplanin expression in peritumoral keratinocytes predicts aggressive behavior in extramammary Paget's disease. Cho Z; Konishi E; Kanemaru M; Isohisa T; Arita T; Kawai M; Tsutsumi M; Mizutani H; Takenaka H; Ozawa T; Tsuruta D; Katoh N; Asai J J Dermatol Sci; 2017 Jul; 87(1):29-35. PubMed ID: 28381343 [TBL] [Abstract][Full Text] [Related]
29. [Observations on signet cell invasion and metastasis in extra-mammary Paget's disease]. Xu H; Li N; Li W Zhonghua Bing Li Xue Za Zhi; 1996 Oct; 25(5):294-5. PubMed ID: 9388876 [TBL] [Abstract][Full Text] [Related]
30. [Extramammary Paget's disease of the scrotum: an analysis of 26 cases]. Zhang ZM Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(28):1970-2. PubMed ID: 22093892 [TBL] [Abstract][Full Text] [Related]
31. Tumor thickness as a prognostic factor in extramammary Paget's disease. Ito T; Kaku Y; Nagae K; Nakano-Nakamura M; Nakahara T; Oda Y; Hagihara A; Furue M; Uchi H J Dermatol; 2015 Mar; 42(3):269-75. PubMed ID: 25557434 [TBL] [Abstract][Full Text] [Related]
32. Transcription factor activating enhancer-binding protein 2B expression correlates with invasiveness and prognosis of extramammary Paget's disease. Kawaguchi A; Akiba J; Ogasawara S; Kondo R; Naito Y; Kusano H; Sanada S; Muto I; Nakama T; Yano H Pathol Res Pract; 2023 Feb; 242():154309. PubMed ID: 36689838 [TBL] [Abstract][Full Text] [Related]
33. Outcomes of lymph node dissection in the treatment of extramammary Paget's disease: A single-institution study. Tsutsui K; Takahashi A; Muto Y; Mizuta H; Jinnai S; Nakama K; Ogata D; Namikawa K; Yamazaki N J Dermatol; 2020 May; 47(5):512-517. PubMed ID: 32157716 [TBL] [Abstract][Full Text] [Related]
34. Invasive extramammary Paget's disease and the risk for secondary tumours in Europe. van der Zwan JM; Siesling S; Blokx WA; Pierie JP; Capocaccia R Eur J Surg Oncol; 2012 Mar; 38(3):214-21. PubMed ID: 22244907 [TBL] [Abstract][Full Text] [Related]
35. Definitive radiation therapy for extramammary Paget's disease. Hata M; Koike I; Wada H; Miyagi E; Odagiri K; Minagawa Y; Kasuya T; Kaizu H; Inoue T Anticancer Res; 2012 Aug; 32(8):3315-20. PubMed ID: 22843908 [TBL] [Abstract][Full Text] [Related]
36. Multiple lymphadenopathy as an initial sign of extramammary Paget disease. Hirakawa S; Tanemura A; Mori H; Katayama I; Hashimoto K Br J Dermatol; 2011 Jan; 164(1):200-3. PubMed ID: 20849466 [TBL] [Abstract][Full Text] [Related]
37. Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease. Kuivanen T; Tanskanen M; Jahkola T; Impola U; Asko-Seljavaara S; Saarialho-Kere U J Cutan Pathol; 2004 Aug; 31(7):483-91. PubMed ID: 15239678 [TBL] [Abstract][Full Text] [Related]
38. Concordant overexpression of phosphorylated ATF2 and STAT3 in extramammary Paget's disease. Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Tomoeda H; Uenotsuchi T; Tu YT; Furue M; Urabe K J Cutan Pathol; 2009 Apr; 36(4):402-8. PubMed ID: 19278424 [TBL] [Abstract][Full Text] [Related]
39. Oncogenic mutations in extramammary Paget's disease and their clinical relevance. Kang Z; Xu F; Zhang QA; Wu Z; Zhang X; Xu J; Luo Y; Guan M Int J Cancer; 2013 Feb; 132(4):824-31. PubMed ID: 22821211 [TBL] [Abstract][Full Text] [Related]
40. A flow cytometric analysis of the DNA content of Paget cells in the epidermis and the tumor of extramammary Paget's disease. Mori O; Hachisuka H; Maeyama Y; Sasai Y Acta Histochem; 1995 Jan; 97(1):99-104. PubMed ID: 7771188 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]